interim results of sc foslevodopa/foscarbidopa in parkinson’s disease
Published 2 years ago • 880 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
1:20
foslevodopa/foscarbidopa improves nocturia symptoms in patients with parkinson’s disease
-
0:50
subcutaneous levodopa/carbidopa infusion for parkinson's disease
-
3:02
subcutaneous 24-hour infusion of foslevodopa/foscarbidopa improves motor symptoms in pd patients
-
1:27
updates on levodopa infusion therapies for advanced parkinson’s disease
-
1:33
final results of duoglobe: real-world evidence for lgic in advanced parkinson’s disease
-
2:37
long-term effectiveness of levodopa-carbidopa intestinal gel in parkinson's disease
-
1:29
benefits and challenges associated with subcutaneous infusions for parkinson’s disease
-
3:02
improvements to levodopa-based treatments for parkinson’s disease
-
2:35
levodopa dose adjustment versus adjunctive therapy in parkinson’s disease
-
3:31
emerging subcutaneous infusions for pd: efficacy & infusion site reactions
-
1:13
extending the efficacy of levodopa in patients with parkinson’s disease
-
18:15
long-acting, subcutaneous levodopa in parkinson's disease: is it safe?
-
2:20
phase ii study of ne3107 in levodopa/carbidopa-treated patients with parkinson's disease
-
4:39
levodopa and the pharmacological revolution in parkinson's disease
-
0:51
emerging levodopa-based treatment strategies for pd: sc delivery
-
0:51
how can continuous dopaminergic delivery improve outcomes in pd?
-
0:53
effects of apomorphine sublingual film on qt interval in patients with parkinson's disease
-
3:20
parkinson's disease: what’s to come in 2022?
-
0:58
ean/mds guideline on invasive therapies for parkinson's disease